Zvika Slovin

Healthcare, investor and executive

📍 Israel, Israel🔄 Updated September 2026💼 8 investments📅 18 years investing🗓 Last invested Jan 2024
Operator-angel🌍 Israel
8
Total investments
1
Early stage
1
Mid stage
2
Late stage
18y
Years active

Portfolio

5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Executive Board Member
Jan 2017
Nitinotes is a privately-held medical device company based in Caesarea, Israel that focuses on providing a safer and simpler suturing solution for endoscopic gastroplasty. Its flagship product, the EndoZip™, is an endoscopic robotic suturing system that has been backed by clinical success and prominent KOLs. By simplifying and speeding up the suturing process, EndoZip™ makes endoscopic gastroplasty a widely available, easy-to-perform procedure that offers an effective and minimally-invasive solution for more than 700 million patients with obesity class I & II for whom traditional bariatric surgery is not an option.
Board Member and Investor
Jul 2008
Kyma Medical Technologies is dedicated to the development and commercialization of innovative patient monitoring solutions, designed to improve care of patients suffering from chronic cardiac illnesses. The company has developed a proprietary technology for the detection and monitoring of changes in fluid contents, based on a proprietary RF sensing technology. Kyma’s solutions are uniquely designed to provide healthcare professionals with accurate and reliable information on the patient's clinical status for support of medical decision-making.
Board Member and Investor
Feb 2008
BrainsGate is a medical device company committed to developing innovative therapies for patients suffering from Central Nervous System (CNS) diseases. The company's platform technology involves electrical stimulation of the Spheno-Palatine Ganglion (SPG), a nervous center known to increase cerebral blood flow. BrainsGate is exploring several applications for its technology, and is currently focusing on two directions: treatment of acute ischemic stroke, and chronic SPG stimulation to treat vascular dementia patients.
Board Member and investor
Jan 2008
Notal Vision is a patient-centric ophthalmic remote monitoring services provider extending retinal disease monitoring from the clinic to the home, providing physicians with remote monitoring services to support their patient care between office visits. With a proven approach to home-based, self-operated diagnostics, AI-enabled data analysis, and patient engagement, we help preserve patients’ vision. The Notal Vision Monitoring Center is a remote, Medicare credentialed ophthalmic provider and the epicenter of patient engagement. Led by practicing ophthalmologists and supported by certified ophthalmic professionals, the Monitoring Center offers a comprehensive nationwide age-related macular degeneration (AMD) home monitoring service for referred patients. The ForeseeHome® AMD Monitoring Program helps physicians detect the conversion to wet AMD early, leading to earlier treatment intervention and better visual outcomes. Our Home OCT pipeline technology will provide patient-initiated retinal OCT scans to support the management of patients with neovascular retinal diseases, complementing existing in-office imaging and standard of care treatments as well as emerging longer acting drugs and drug delivery systems.
Board member and Investor
2008
POCARED Diagnostics Ltd. is the developer of leading technologies platforms. The P-1000™ uses the unique physical properties of intrinsic fluorescence to provide the fully automated, direct specimen, CULTURE-FREE Microbiology® and reagent- free solution for microorganism detection, identification and enumeration. The SP (Sample Processor) offers the world's first general use, automated cell fractionate concentrator that introduces sample purification, organism recovery and viability second to none.
Experience · 11 entries
All (11)
Investments (8)
Founder (3)
Board (8)
2024
Board Member
Jan 2024
BioGenCell was founded with the vision of developing safe, effective, and long-lasting effective treatment for incurable, blood vessel diseases that will be both accessible and patient friendly. Our disruptive TRACT technology platform provides a comprehensive approach for rapid manufacturing and commercialization of cell-therapies.
2017
Executive Board Member
Jan 2017
Nitinotes is a privately-held medical device company based in Caesarea, Israel that focuses on providing a safer and simpler suturing solution for endoscopic gastroplasty. Its flagship product, the EndoZip™, is an endoscopic robotic suturing system that has been backed by clinical success and prominent KOLs. By simplifying and speeding up the suturing process, EndoZip™ makes endoscopic gastroplasty a widely available, easy-to-perform procedure that offers an effective and minimally-invasive solution for more than 700 million patients with obesity class I & II for whom traditional bariatric surgery is not an option.
2008
Board Member and Investor
Jul 2008
Kyma Medical Technologies is dedicated to the development and commercialization of innovative patient monitoring solutions, designed to improve care of patients suffering from chronic cardiac illnesses. The company has developed a proprietary technology for the detection and monitoring of changes in fluid contents, based on a proprietary RF sensing technology. Kyma’s solutions are uniquely designed to provide healthcare professionals with accurate and reliable information on the patient's clinical status for support of medical decision-making.
Board Member
May 2008
Galil Medical is part of Boston Scientific since August 2019
Board Member and Investor
Feb 2008
BrainsGate is a medical device company committed to developing innovative therapies for patients suffering from Central Nervous System (CNS) diseases. The company's platform technology involves electrical stimulation of the Spheno-Palatine Ganglion (SPG), a nervous center known to increase cerebral blood flow. BrainsGate is exploring several applications for its technology, and is currently focusing on two directions: treatment of acute ischemic stroke, and chronic SPG stimulation to treat vascular dementia patients.
Show all 11 entries ↓
Investment activity
2008–2024 · 8 investments
200862017120241
Recent (last 2 years)Earlier